评估抗癌药物3D协调聚合物的药物输送能力
Madiha Saqlain1, Hafiz Muhammad Zohaib1, Maroof Ahmad Khan2
1Key Laboratory of Cluster Science of Ministry of Education, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing, 100081, P. R. China.
Chemistry, an Asian journal
|February 4, 2025
概括
一种新型的协调聚合物 (CP-1) 显示出对抗癌药物多克索鲁比 (DOX) 的负载潜力. 在pH 7下发生最佳负荷,而pH 5则通过扩散促进受控释放,达到87.11%的释放.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 开发高效的药物输送系统对于癌症治疗至关重要.
- 金属有机框架和协调聚合物为药物封装提供多孔结构.
- 像多克索鲁比 (DOX) 这样的抗癌药物的受控释放仍然是一个挑战.
研究的目的:
- 为了合成和描述一种新的3D金属核酸协调聚合物 (CP-1).
- 使用 CP-1 调查多克索鲁比 (DOX) 的封装和pH响应释放.
- 通过实验和模拟方法探索药物加载和释放机制.
主要方法:
- 一种新的3D金属核酸协调聚合物的合成, {[Cd2(dTMP) 2(4,4'-基) 2(H2O) 2) ·3(O) }n (CP-1).
- 分子动态模拟用于虚拟选与多克索鲁比 (DOX) 的结合亲和力.
- 紫外线可见和圆形二极化定位以研究DOX封装和在不同pH (8,7,6,5) 时释放动力学.
- 使用希古奇方程和MD模拟数据 (能量图,RMSD,Rg) 分析释放机制.
主要成果:
- CP-1 显示出对抗癌症药物多克索鲁比 (DOX) 进行封装的显著潜力.
- 在pH 7下观察到对DOX的高度亲和力,从而促进对3D多孔结构的有效加载.
- 在pH5下达到最大累积药物释放率87.11%,释放主要由扩散 (希古奇模型) 控制.
结论:
- 合成的CP-1具有很好的潜力,可以作为多克索鲁比的药物载体.
- 该材料显示了pH响应的控制释放能力,这对于向癌症治疗至关重要.
- 综合实验和模拟数据证实了CP-1在封装DOX和启用扩散控制释放机制方面的有效性.
相关概念视频
Drug Distribution: Tissue Binding
3.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.7K
Tissue-Drug Binding: Localization of Drugs and its Significance
598
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
598
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


